Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Concordia Healthcare Corp. T.CXR.R

TSX:CXR.R - Post Discussion

Concordia Healthcare Corp. > Anyone who is in CXRX
View:
Post by DownHuge on Jan 28, 2017 9:33am

Anyone who is in CXRX

The market has set all time highs this week ...  and the bulls here seem to argue over if this is or is not a good short.  Seriously, people ...   it is a great short.  If you can't short it then go long on something that at least doesn't have this as its bull thesis:  "We believe we can meet near-term debt obligatons." 

Long term, thy have no R&D so where is the organic growth going to come from now that their Photofrin trials have been cancelled?  

Pricing pressure over in the UK when the bill gets approved soon and Trump said the pharma companies have been getting away with murder. Who are you kidding?
Comment by DownHuge on Jan 28, 2017 9:53am
Forgot to post the link https://www.reuters.com/video/2017/01/25/breakingviews-tv-shkreli-shreds-pharma?videoId=370993916&videoChannel=117766
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities